Raffaele De Caterina

92.2k total citations · 5 hit papers
659 papers, 24.4k citations indexed

About

Raffaele De Caterina is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine. According to data from OpenAlex, Raffaele De Caterina has authored 659 papers receiving a total of 24.4k indexed citations (citations by other indexed papers that have themselves been cited), including 381 papers in Cardiology and Cardiovascular Medicine, 193 papers in Surgery and 88 papers in Internal Medicine. Recurrent topics in Raffaele De Caterina's work include Atrial Fibrillation Management and Outcomes (176 papers), Antiplatelet Therapy and Cardiovascular Diseases (118 papers) and Venous Thromboembolism Diagnosis and Management (88 papers). Raffaele De Caterina is often cited by papers focused on Atrial Fibrillation Management and Outcomes (176 papers), Antiplatelet Therapy and Cardiovascular Diseases (118 papers) and Venous Thromboembolism Diagnosis and Management (88 papers). Raffaele De Caterina collaborates with scholars based in Italy, United States and United Kingdom. Raffaele De Caterina's co-authors include Rosalinda Madonna, Marika Massaro, Peter Libby, Maria Annunziata Carluccio, James K. Liao, Egeria Scoditti, Marco Zimarino, Fabrizio Ricci, Gregory Y.H. Lip and Paulus Kirchhof and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Raffaele De Caterina

617 papers receiving 23.6k citations

Hit Papers

Nitric oxide decreases cytokine-induced endothelial activ... 1995 2026 2005 2015 1995 2016 2012 2011 2017 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines.
    1995 1.4k citations Raffaele De Caterina et al. profile →
  2. ESC working group position paper on myocardial infarction with non-obstructive coronary arteries
    2016 564 citations Raffaele De Caterina et al. European Heart Journal profile →
  3. 2012 Focused Update of the ESC Guidelines for the Management of Atrial Fibrillation
    2012 553 citations Raffaele De Caterina, Paulus Kirchhof et al. profile →
  4. n–3 Fatty Acids in Cardiovascular Disease
    2011 435 citations Raffaele De Caterina profile →
  5. Stroke prevention in atrial fibrillation: Past, present and future
    2017 275 citations Raffaele De Caterina et al. Thrombosis and Haemostasis profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raffaele De Caterina Italy 79 11.7k 5.5k 3.3k 3.0k 2.6k 659 24.4k
Carlo Patrono Italy 87 17.6k 1.5× 7.4k 1.3× 4.2k 1.3× 1.2k 0.4× 2.5k 1.0× 369 35.9k
Francesco Violi Italy 78 5.5k 0.5× 3.9k 0.7× 2.9k 0.9× 1.6k 0.5× 3.0k 1.2× 542 20.8k
Elena Tremoli Italy 64 6.3k 0.5× 3.9k 0.7× 3.3k 1.0× 1.5k 0.5× 1.5k 0.6× 482 17.1k
Lina Badimón Spain 86 13.8k 1.2× 11.7k 2.1× 7.8k 2.4× 1.2k 0.4× 2.4k 0.9× 700 35.1k
Ulf Landmesser Germany 86 15.2k 1.3× 10.8k 2.0× 7.0k 2.1× 1.2k 0.4× 5.0k 1.9× 574 34.0k
Malte Kelm Germany 79 9.3k 0.8× 4.2k 0.8× 3.8k 1.1× 1.1k 0.4× 7.5k 2.9× 829 25.0k
Dimitris Tousoulis Greece 68 9.1k 0.8× 3.9k 0.7× 3.8k 1.1× 1.1k 0.4× 3.4k 1.3× 811 20.5k
Roberto Ferrari Italy 77 19.9k 1.7× 5.5k 1.0× 5.6k 1.7× 813 0.3× 2.5k 1.0× 769 31.3k
Stefan Blankenberg Germany 77 10.7k 0.9× 5.1k 0.9× 3.7k 1.1× 715 0.2× 1.7k 0.6× 671 22.0k
Yangsoo Jang South Korea 69 9.8k 0.8× 10.9k 2.0× 2.9k 0.9× 783 0.3× 1.6k 0.6× 953 22.4k

Countries citing papers authored by Raffaele De Caterina

Since Specialization
Citations

This map shows the geographic impact of Raffaele De Caterina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raffaele De Caterina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raffaele De Caterina more than expected).

Fields of papers citing papers by Raffaele De Caterina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raffaele De Caterina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raffaele De Caterina. The network helps show where Raffaele De Caterina may publish in the future.

Co-authorship network of co-authors of Raffaele De Caterina

This figure shows the co-authorship network connecting the top 25 collaborators of Raffaele De Caterina. A scholar is included among the top collaborators of Raffaele De Caterina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raffaele De Caterina. Raffaele De Caterina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Laudani, Claudio, Davide Capodanno, Felice Gragnano, et al.. (2025). Factor XI Inhibitors or Direct Oral Anticoagulants in Atrial Fibrillation: A Focused Meta-analysis. Thrombosis and Haemostasis. 1 indexed citations
2.
Figlioli, Gisella, Alessandro Sticchi, Marco De Carlo, et al.. (2025). Global Prevalence of Mitral Regurgitation: A Systematic Review and Meta-Analysis of Population-Based Studies. Journal of Clinical Medicine. 14(8). 2749–2749.
3.
Caterina, Raffaele De, Martin Unverdorben, Eue‐Keun Choi, et al.. (2025). Two‐Year Follow‐Up of Patients With Atrial Fibrillation Receiving Edoxaban in Routine Clinical Practice: Results From the Global ETNA‐AF Program. Clinical Cardiology. 48(3). e70091–e70091.
4.
Visconti, Luca, et al.. (2024). Inferior vena cava filters: Concept review and summary of current guidelines. Vascular Pharmacology. 155. 107375–107375. 4 indexed citations
5.
Choi, Jong‐Il, Songsak Kiatchoosakun, Hung‐Fat Tse, et al.. (2024). Prescribing Patterns and Outcomes of Edoxaban in Atrial Fibrillation Patients From Asia　― One-Year Data From the Global ETNA-AF Program ―. Circulation Reports. 6(3). 86–93. 1 indexed citations
6.
Migliorini, Paola, et al.. (2024). Aspirin hypersensitivity: a practical guide for cardiologists. European Heart Journal. 45(19). 1716–1726. 9 indexed citations
7.
Chao, Tze‐Fan, Martin Unverdorben, Paulus Kirchhof, et al.. (2023). Prescribing Patterns and Outcomes of Edoxaban in Atrial Fibrillation: One-Year Data from the Global ETNA-AF Program. Journal of Clinical Medicine. 12(5). 1870–1870. 5 indexed citations
8.
Caterina, Raffaele De, Riccardo Liga, & William E. Boden. (2021). Myocardial revascularization in ischaemic cardiomyopathy: routine practice vs. scientific evidence. European Heart Journal. 43(5). 387–390. 11 indexed citations
9.
Boriani, Giuseppe, et al.. (2021). Impact of Weight on Clinical Outcomes of Edoxaban Therapy in Atrial Fibrillation Patients Included in the ETNA-AF-Europe Registry. Journal of Clinical Medicine. 10(13). 2879–2879. 6 indexed citations
10.
Madonna, Rosalinda, Stefania Moscato, Damiana Pieragostino, et al.. (2021). Connexin 43 and Connexin 26 Involvement in the Ponatinib-Induced Cardiomyopathy: Sex-Related Differences in a Murine Model. International Journal of Molecular Sciences. 22(11). 5815–5815. 14 indexed citations
11.
Liga, Riccardo, Marco De Carlo, & Raffaele De Caterina. (2021). Antiplatelet therapy in patients with acute coronary syndromes and thrombocytopaenia: awaiting for evidence. European Heart Journal - Case Reports. 5(2). ytaa577–ytaa577. 1 indexed citations
12.
13.
Massaro, Marika, Egeria Scoditti, Maria Annunziata Carluccio, et al.. (2020). Effects of Olive Oil on Blood Pressure: Epidemiological, Clinical, and Mechanistic Evidence. Nutrients. 12(6). 1548–1548. 44 indexed citations
14.
Angelillis, Marco, Marco De Carlo, Michele Marconi, et al.. (2020). A case report of multisite arterial thrombosis in a patient with coronavirus disease 2019 (COVID-19). European Heart Journal - Case Reports. 5(1). ytaa339–ytaa339. 8 indexed citations
15.
Madonna, Rosalinda, Damiana Pieragostino, Maria Concetta Cufaro, et al.. (2020). Ponatinib Induces Vascular Toxicity through the Notch-1 Signaling Pathway. Journal of Clinical Medicine. 9(3). 820–820. 21 indexed citations
16.
Francisci, Daniela, Matteo Pirro, Elisabetta Schiaroli, et al.. (2019). Maraviroc Intensification Modulates Atherosclerotic Progression in HIV-Suppressed Patients at High Cardiovascular Risk. A Randomized, Crossover Pilot Study. Open Forum Infectious Diseases. 6(4). ofz112–ofz112. 42 indexed citations
17.
Briguori, Carlo, Cristina Quintavalle, Michael Donahue, et al.. (2017). Impact of statin therapy intensity on endothelial progenitor cells after percutaneous coronary intervention in diabetic patients. The REMEDY-EPC late study. International Journal of Cardiology. 244. 112–118. 12 indexed citations
18.
Renda, Giulia, Fabrizio Ricci, & Raffaele De Caterina. (2016). Non-Vitamin K Antagonist Oral Anticoagulants for Cardioversion in Atrial Fibrillation: An Updated Meta-analysis. The American Journal of Medicine. 130(4). 457–461. 13 indexed citations
19.
Caterina, Raffaele De, et al.. (2014). La gestione del rischio tromboembolico nei pazienti con fibrillazione atriale in Italia: dati al basale del Registro Europeo PREFER in AF. Giornale italiano di cardiologia. 15(2). 922–109. 9 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carlo Patrono Breakdown of academic impact, for papers by Francesco Violi Breakdown of academic impact, for papers by Elena Tremoli Breakdown of academic impact, for papers by Lina Badimón Breakdown of academic impact, for papers by Ulf Landmesser Breakdown of academic impact, for papers by Malte Kelm Breakdown of academic impact, for papers by Dimitris Tousoulis Breakdown of academic impact, for papers by Roberto Ferrari Breakdown of academic impact, for papers by Stefan Blankenberg Breakdown of academic impact, for papers by Yangsoo Jang
Rankless by CCL
2026